<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id><journal-id journal-id-type="pmc-domain-id">1609</journal-id><journal-id journal-id-type="pmc-domain">bmjo</journal-id><journal-id journal-id-type="publisher-id">bmjopen</journal-id><journal-title-group><journal-title>BMJ Open</journal-title></journal-title-group><issn pub-type="epub">2044-6055</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10230879</article-id><article-id pub-id-type="pmcid-ver">PMC10230879.1</article-id><article-id pub-id-type="pmcaid">10230879</article-id><article-id pub-id-type="pmcaiid">10230879</article-id><article-id pub-id-type="pmid">37225265</article-id><article-id pub-id-type="doi">10.1136/bmjopen-2022-069230</article-id><article-id pub-id-type="publisher-id">bmjopen-2022-069230</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Emergency Medicine</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject><subject>1691</subject></subj-group><series-title>Protocol</series-title></article-categories><title-group><article-title>Impact of vitamin C on the reduction of opioid consumption after an emergency department visit for acute musculoskeletal pain: a double-blind randomised control trial protocol</article-title></title-group><contrib-group><contrib id="author-34732017" contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6507-0198</contrib-id><name name-style="western"><surname>Daoust</surname><given-names initials="R">Raoul</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib id="author-34764114" contrib-type="author"><name name-style="western"><surname>Paquet</surname><given-names initials="J">Jean</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib id="author-31983922" contrib-type="author"><name name-style="western"><surname>Chauny</surname><given-names initials="JM">Jean-Marc</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib id="author-52784567" contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3360-4831</contrib-id><name name-style="western"><surname>Williamson</surname><given-names initials="D">David</given-names></name><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib id="author-102331813" contrib-type="author"><name name-style="western"><surname>Huard</surname><given-names initials="V">V&#233;rilibe</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib id="author-66479664" contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9952-0588</contrib-id><name name-style="western"><surname>Arbour</surname><given-names initials="C">Caroline</given-names></name><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib id="author-40348519" contrib-type="author"><name name-style="western"><surname>Emond</surname><given-names initials="M">Marcel</given-names></name><xref rid="aff6" ref-type="aff">6</xref></contrib><contrib id="author-102331816" contrib-type="author"><name name-style="western"><surname>Rouleau</surname><given-names initials="D">Dominique</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib id="author-59434397" contrib-type="author"><name name-style="western"><surname>Cournoyer</surname><given-names initials="A">Alexis</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref></contrib></contrib-group><aff id="aff1"><label>1</label><institution content-type="department">D&#233;partement de M&#233;decine Familiale et de M&#233;decine d&#8217;Urgence</institution>, <institution specific-use="Ringgold_5622">Universit&#233; de Montr&#233;al</institution>, <addr-line content-type="city">Montreal</addr-line>, <addr-line content-type="state">Quebec</addr-line>, <country>Canada</country></aff><aff id="aff2"><label>2</label><institution content-type="department">Study Center in Emergency Medicine</institution>, <institution specific-use="Ringgold_574177">Hopital du Sacre-Coeur de Montreal Centre de Recherche</institution>, <addr-line content-type="city">Montreal</addr-line>, <addr-line content-type="state">Quebec</addr-line>, <country>Canada</country></aff><aff id="aff3"><label>3</label><institution content-type="department">Centre de Recherche</institution>, <institution specific-use="Ringgold_574177">Hopital du Sacre-Coeur de Montreal</institution>, <addr-line content-type="city">Montreal</addr-line>, <addr-line content-type="state">Quebec</addr-line>, <country>Canada</country></aff><aff id="aff4"><label>4</label><institution content-type="department">Facult&#233; de Pharmacie</institution>, <institution specific-use="Ringgold_5622">Universit&#233; de Montr&#233;al</institution>, <addr-line content-type="city">Montreal</addr-line>, <addr-line content-type="state">Quebec</addr-line>, <country>Canada</country></aff><aff id="aff5"><label>5</label><institution content-type="department">Facult&#233; des sciences infirmi&#232;res</institution>, <institution>Universit&#233; de Montr&#233;al</institution>, <addr-line content-type="city">Montr&#233;al</addr-line>, <addr-line content-type="state">Qu&#233;bec</addr-line>, <country>Canada</country></aff><aff id="aff6"><label>6</label><institution content-type="department">Department of Family and Emergency Medicine</institution>, <institution specific-use="Ringgold_4440">Universite Laval</institution>, <addr-line content-type="city">Quebec</addr-line>, <addr-line content-type="state">Quebec</addr-line>, <country>Canada</country></aff><author-notes><corresp><label>Correspondence to</label> Dr Raoul Daoust; <email>raoul.daoust@umontreal.ca</email></corresp></author-notes><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>23</day><month>5</month><year>2023</year></pub-date><volume>13</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">435194</issue-id><elocation-id>e069230</elocation-id><history><date date-type="received"><day>14</day><month>10</month><year>2022</year></date><date date-type="accepted"><day>28</day><month>4</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>23</day><month>05</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>01</day><month>06</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-29 16:25:13.610"><day>29</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</copyright-statement><copyright-year>2023</copyright-year><ali:free_to_read/><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense" start_date="2023-05-23">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:&#160;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="bmjopen-2022-069230.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="bmjopen-2022-069230.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="reviewers-comments-pdf" xlink:href="bmjopen-2022-069230.reviewer_comments.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="draft-revisions-pdf" xlink:href="bmjopen-2022-069230.draft_revisions.pdf"/><abstract><sec><title>Introduction</title><p>Recent evidence has shown that vitamin C has some analgesic properties in addition to its antioxidant effect and can, therefore, reduce opioid use during recovery time. Vitamin C analgesic effect has been explored mostly during short-term postoperative context or in disease-specific chronic pain prevention, but never after acute musculoskeletal injuries, which are often seen in the emergency department (ED). The protocol&#8217;s primary aim is to compare the total morphine 5&#8201;mg pills consumed during a 2-week follow-up between patients receiving vitamin C or a placebo after ED discharge for an acute musculoskeletal pain complaint.</p></sec><sec><title>Methods and analysis</title><p>We will conduct a two-centre double-blind randomised placebo-controlled trial with 464 participants distributed in two arms, one group receiving 1000&#8201;mg of vitamin C two times a day for 14 days and another one receiving a placebo. Participants will be &#8805;18 years of age, treated in ED for acute musculoskeletal pain present for less than 2&#8201;weeks and discharged with an opioid prescription for home pain management. Total morphine 5&#8201;mg pills consumed during the 2-week follow-up will be assessed via an electronic (or paper) diary. In addition, patients will report their daily pain intensity, pain relief, side effects and other types of pain medication or other non-pharmacological approach used. Three months after the injury, participants will also be contacted to evaluate chronic pain development. We hypothesised that vitamin C, compared with a placebo, will reduce opioid consumption during a 14-day follow-up for ED discharged patients treated for acute musculoskeletal pain.</p></sec><sec><title>Ethics and dissemination</title><p>This study has received approval from the Ethics Review Committee from the &#8216;Comit&#233; d'&#233;thique de la recherche du CIUSSS du Nord-de-l'&#206;le-de-Montr&#233;al (No 2023&#8211;2442)&#8217;. Findings will be disseminated through scientific conferences and peer-reviewed journal publication. The data sets generated during the study will be available from the corresponding author on reasonable request.</p></sec><sec><title>Trial registration number</title><p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NCT05555576" ext-link-type="uri" specific-use="clinicaltrial results">NCT05555576</ext-link> ClinicalTrials.Gov PRS.</p></sec></abstract><kwd-group><kwd>Pain management</kwd><kwd>Accident &amp; emergency medicine</kwd><kwd>Trauma management</kwd></kwd-group><funding-group specific-use="FundRef"><award-group id="funding-1"><funding-source><institution-wrap><institution>Fonds des Urgentistes de l&#8217;H&#244;pital du Sacr&#233;-C&#339;ur de Montr&#233;al</institution></institution-wrap></funding-source><award-id>N/A</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>special-feature</meta-name><meta-value>unlocked</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>STRENGTHS AND LIMITATIONS OF THIS STUDY</title></caption><list list-type="bullet"><list-item><p>This randomised controlled trial evaluating the effects of vitamin C on short-term opioid consumption in emergency department discharge patients with acute musculoskeletal injuries is novel.</p></list-item><list-item><p>The advantages of using vitamin C as treatment remain its low toxicity and low side effects.</p></list-item><list-item><p>This study is performed only on acute musculoskeletal injuries in two academic centres and may not generalise to other types of painful conditions or centres.</p></list-item><list-item><p>This study excludes patients already using opioids or vitamin C, patients treated for cancer, chronic pain or opioid use disorder.</p></list-item><list-item><p>There might be confounding factors not addressed by the randomisation and the compliance may be inconsistent.</p></list-item></list></boxed-text><sec sec-type="intro" id="s1"><title>Introduction</title><p>Opioids remain an important part of the treatment for moderate to severe acute pain in the emergency department (ED) and are frequently prescribed for home pain management after ED discharge.<xref rid="R1" ref-type="bibr">1 2</xref> However, even short-term opioids&#8217; use after an ED visit can cause undesirable side effects like constipation, nausea/vomiting, drowsiness, weakness<xref rid="R3" ref-type="bibr">3</xref> and can also produce more severe adverse events like respiratory depression.<xref rid="R4" ref-type="bibr">4</xref> It can also lead to long-term use,<xref rid="R5" ref-type="bibr">5 6</xref> opioid use disorders,<xref rid="R7" ref-type="bibr">7</xref> overdose and death.<xref rid="R8" ref-type="bibr">8 9</xref> Furthermore, larger quantity of opioid consumed is associated with a higher prevalence of opioid-related adverse events.<xref rid="R10" ref-type="bibr">10</xref> Therefore, reducing opioid consumption for acute pain without compromising the patients&#8217; home pain management is a constant challenge for clinicians.<xref rid="R11" ref-type="bibr">11</xref></p><p>Currently, the main strategy employed to reduce opioid consumption is to limit the rate and/or the quantity of opioids prescribed for acute pain.<xref rid="R12" ref-type="bibr">12&#8211;15</xref> The efficacy of this approach to reduce the quantity of opioid prescribed remains low and studies rarely report patient-centred outcomes such as pain relief or patients&#8217; satisfaction.<xref rid="R16" ref-type="bibr">16</xref> Yet, using adjunct analgesia was associated with less pain and opioid use.<xref rid="R17" ref-type="bibr">17</xref> Non-steroid anti-inflammatory drugs (NSAIDs) are frequently suggested as adjuvants to reduce opioid consumption but are known to contribute to gastrointestinal, cardiovascular, musculoskeletal (MSK) and renal adverse effects.<xref rid="R18" ref-type="bibr">18 19</xref> Recent evidence showed that vitamin C (ascorbic acid) has analgesic properties by adding, through an unknown mechanism, an antinociceptive action to its antioxidant effect.<xref rid="R20" ref-type="bibr">20&#8211;22</xref> One potential mechanism is to reduce free radicals&#8217; production, which helps protect tissues (including nerves) from irreversible damage.<xref rid="R23" ref-type="bibr">23 24</xref> The advantages of using vitamin C as adjuvant to opioids in acute pain management remain its low toxicity and low side effects, also in addition to performing well in different types of pain disorders.<xref rid="R25" ref-type="bibr">25</xref></p><p>Two meta-analysis reported the effects of vitamin C for immediate postoperative pain. One found a moderate-level evidence supporting the use of a 2&#8201;g oral preoperative dose of vitamin C as an adjunct for reducing postoperative morphine consumption.<xref rid="R26" ref-type="bibr">26</xref> The other showed significant reductions in pain scores and opioid requirements up to 24&#8201;hours postoperative, suggesting the effectiveness of perioperative (on the day of the surgery or up to 30&#8201;min after the surgery&#8217;s beginning) vitamin C use.<xref rid="R27" ref-type="bibr">27</xref> One study using 500&#8201;mg intravenously two times a day up to the third day after surgery also demonstrated less pain intensity and opioid consumption with vitamin C.<xref rid="R28" ref-type="bibr">28</xref> Taking 200&#8201;mg orally of vitamin C three times a day, for 10 days after tooth extraction, was associated with reduced postoperative pain. However, this small study did not find any difference between 600&#8201;mg and 1500&#8201;mg per day of vitamin C.<xref rid="R29" ref-type="bibr">29</xref> The only study performed in a non-postoperative acute pain context showed that intravenous administration of vitamin C was effective in reducing the incidence of post-herpetic neuralgia.<xref rid="R30" ref-type="bibr">30</xref></p><p>The efficacy of vitamin C to prevent specific types of chronic pain, notably in complex regional pain syndromes (CRPS), has been reported in a meta-analysis.<xref rid="R31" ref-type="bibr">31</xref> Using a daily regimen of at least 500&#8201;mg of oral vitamin C initiated immediately after extremity surgery or injury and continued for 45 to 50 days, all studies showed a significant decrease of CRPS incidence up to 90 days after the event. Two other meta-analyses showed that daily supplementation with 500&#8201;mg of vitamin C for 50 days decreased the 1-year risk of CRPS after wrist fracture or limb extremity fractures.<xref rid="R32" ref-type="bibr">32 33</xref> Taking 1&#8201;g per day of vitamin C for 40 days after a total knee arthroplasty also reduces CRPS risk.<xref rid="R34" ref-type="bibr">34</xref> Yet, a literature synthesis on the effect of vitamin C on CRPS after distal radius fracture found a decrease in efficacy in recent studies.<xref rid="R35" ref-type="bibr">35</xref></p><sec id="s1-1"><title>Study rationale</title><p>The literature suggests that administration of vitamin C has an effect in reducing pain and opioid consumption in the context of immediate postoperative acute pain (24 to 72&#8201;hours), which is similar to pain caused by trauma seen in ED. However, we could not find evidence on the effectiveness of vitamin C administration after an ED visit in the context of acute pain, notably in trauma injuries like fractures, bruises, sprains, strains, etc. Therefore, we propose to evaluate the efficacy of a 14-day regiment of vitamin C given to ED patients discharged with an opioid prescription for acute MSK pain on total opioid consumption after 2&#8201;weeks. The 2-week period was chosen because it defines the usual acute pain timeframe,<xref rid="R36" ref-type="bibr">36</xref> during which the need for analgesics including opioids is essentially resolved in most patients (88% of our previous study cohort).<xref rid="R37" ref-type="bibr">37</xref> Since vitamin C is also associated with less postherpetic neuralgia and CRPS, we also propose to evaluate its impact on the incidence of chronic pain and CRPS at 3&#8201;months.</p></sec><sec id="s1-2"><title>Study objectives</title><p>The primary aim of this protocol is to evaluate the effectiveness of vitamin C, compared with placebo (lactose), in reducing the total morphine 5&#8201;mg pills consumed during a 2-week period following ED discharge for an acute MSK pain complaint.</p><p>The secondary aims are to compare the following between patients receiving vitamin C and patients receiving a placebo: pain intensity trajectories, average pain relief during the 2&#8201;week, side effects, total morphine 5&#8201;mg pills consumed after a 2-week follow-up for each type of MSK pain (fracture, contusion, cervical pain, lower back pain, MSK pain at other sites), global chronic pain incidence (including CRPS) at 3&#8201;months and for each type of MSK pain specifically, CRPS incidence for limb factures and for wrist fracture at 3&#8201;months, and prevalence of opioid use at 3&#8201;months.</p></sec></sec><sec sec-type="methods" id="s2"><title>Methods and analyses</title><sec id="s2-1"><title>Study design</title><p>We will conduct a double-blind, randomised, placebo-controlled trial performed in two tertiary trauma care university-affiliated hospitals located in Montreal and Quebec City (Qu&#233;bec, Canada) with an annual census of 60&#8201;000 and 67&#8201;000 visits, respectively. This parallel group randomised trial will be reported in accordance with the Consolidated Standards of Reporting Trials (CONSORT 2010) statement for reporting parallel-group randomised trial.<xref rid="R38" ref-type="bibr">38</xref> This protocol has been reported according to Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)(<xref rid="SP1" ref-type="supplementary-material">online supplemental file online l</xref>).<xref rid="R39" ref-type="bibr">39</xref></p><supplementary-material id="SP1" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1136/bmjopen-2022-069230.supp1</object-id><label>Supplementary data</label><p>
<inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" id="SS1" xlink:href="bmjopen-2022-069230supp001.pdf" content-type="local-data"/>
</p></supplementary-material></sec><sec id="s2-2"><title>Participants and recruitment</title><p>Consecutive patients (from 8 hours to 20&#8201;hours every day) diagnosed with an acute MSK pain complaint ongoing for less than 2&#8201;weeks and discharged from the ED with an opioid prescription will be approached by the treating clinician to participate in the study and obtain their verbal consent to be seen by a research assistant. The decision to prescribe opioids will be at the treating physician&#8217;s discretion. Based on our previous work,<xref rid="R37" ref-type="bibr">37</xref> all included patients will receive an identical 20 pills of 5&#8201;mg morphine prescription. The research assistant will then verify the patient&#8217;s inclusion and exclusion criteria, explain the research protocol and obtain informed written consent.</p><sec id="s2-2-1"><title>Eligibility criteria</title><p>Patients will be included in the study when they satisfy all following criteria: (1) aged 18 and over, (2) treated in ED for acute MSK pain present for less than 2 weeks, (3) discharged with an opioid prescription, (4) French or English speaking.</p><p>Patients will be excluded from the study if any of the following criteria apply: (1) opioid use 1&#8201;month prior to ED visit; (2) already taking vitamin C supplement<xref rid="R40" ref-type="bibr">40</xref>; (3) active cancer; (4) treated for chronic pain; (5) treated for opioid use disorder; (6) unable to fill out diary or unavailable for follow-up; (7) any allergy, intolerance or sensitivity to milk or morphine; (8) treated with cyclosporine or warfarin; (9) pre-existing oxalate nephropathy or hemochromatosis<xref rid="R41" ref-type="bibr">41 42</xref>; (10) pregnant or lactating (dosage &gt;1800&#8201;mg not recommended).<xref rid="R43" ref-type="bibr">43</xref> For women of childbearing age and sexually active in the past 3 months, urine pregnancy test will be performed.</p></sec><sec id="s2-2-2"><title>Randomisation method and blinding</title><p>Eligible patients will be block randomised at the initial visit (via 1:1 ratio) to either 1 000&#8201;mg vitamin C taken orally two times a day or matching placebo (lactose) (<xref rid="F1" ref-type="fig">figure 1</xref>), using a centralised randomisation web system. Allocation concealment will be in place to ensure that the investigator and the individual enrolling the subject into the study have no prior knowledge of group assignment. Since fractures are associated with more opioid consumption, randomisation will be a stratified by fracture (yes or no) and by centre.<xref rid="R37" ref-type="bibr">37 44</xref> According to the centralised web system, an independent pharmacist will dispense prepacked numbered bottles of either vitamin C or placebo capsules for each patient. Both will be dispensed in identical capsule and the pharmacist will be unaware of the trial-group assignments. Each participant will be assigned a number and received the capsules in the corresponding prepacked bottle. Group allocation will be disclosed only after final analysis or at the request of the patient&#8217;s treating clinician.</p><fig position="float" id="F1" orientation="portrait"><label>Figure 1</label><caption><p>Flowchart of patients&#8217; enrolment in the study.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="bmjopen-2022-069230f01.jpg"/></fig></sec><sec id="s2-2-3"><title>Early withdrawal of subjects</title><p>At the time of consent, participants will be informed that their participation in this research is voluntary and that they may discontinue participation at any time.</p></sec><sec id="s2-2-4"><title>Withdrawal of subject as the result of investigator decision</title><list list-type="order"><list-item><p>If an investigator terminates a subject&#8217;s participation in the trial, the investigator will explain to the subject the reasons for this action and, as appropriate, other treatment options.</p></list-item><list-item><p>If subjects were to have a serious adverse reaction to the medication, the investigator will recommend discontinuation of medication and provide aid for treatment.</p></list-item></list></sec><sec id="s2-2-5"><title>Data collection and follow-up for withdrawn subjects</title><p>Data collected prior to participant withdrawal may be retained and used including Protected Personally Identifiable Information in a manner that is consistent with the study purpose and procedures as noted in this protocol and supplemental documents, unless a study participant notifies the primary investigator to remove all its information from the study.</p></sec></sec><sec id="s2-3"><title>Study drug</title><p>Vitamin C (ascorbic acid) is a vital nutrient; it helps form and maintain bones, skin and blood vessels and has antioxidant properties. It is not produced by the human body but occurs naturally in fruits, vegetables and other foods. It is also available as supplement over the counter in pharmacies, supermarkets, health supplement stores, and online.</p><sec id="s2-3-1"><title>Previous vitamin C dosage used for pain management</title><p>Our study will evaluate the impact of vitamin C in addition to an opioid prescribed for acute pain after an ED discharge. The current recommended dietary allowances of vitamin C are 90 and 75&#8201;mg/day for adult men and women, respectively.<xref rid="R45" ref-type="bibr">45</xref> For anaesthetic or opioid sparing effects, recommended daily doses of vitamin C are larger. Studies on chronic pain management have typically used daily doses of 500&#8201;mg of vitamin C for 50 days to reduce by half the risk of CRPS within the first year.<xref rid="R32" ref-type="bibr">32</xref> In postoperative context, studies generally administered only one dose of 2&#8201;g of vitamin C intravenously or 50&#8201;mg/kg orally just before or after anaesthesia induction and found significant reductions in opioid requirement and in pain severity within 24 to 72&#8201;hours.<xref rid="R27" ref-type="bibr">27</xref> One of these studies used 500&#8201;mg intravenously two times a day up to the third day after surgery.<xref rid="R28" ref-type="bibr">28</xref> The incidence of postherpetic neuralgia was lower after 8 weeks in the group of patients who received three daily doses of 5&#8201;g of vitamin C intravenously during the first 5&#8201;days of hospitalisation.<xref rid="R30" ref-type="bibr">30</xref></p></sec><sec id="s2-3-2"><title>Dose rationale and risk/benefits</title><p>Levine and coworkers have shown that oral vitamin C uptake becomes less efficient as the dose increases due to transporter saturation. Although an oral dose of 200&#8201;mg vitamin C is completely absorbed, doses of 500&#8201;mg and 1250&#8201;mg vitamin C are only absorbed at &lt;75%&#8201;and 50%, respectively.<xref rid="R46" ref-type="bibr">46</xref> Therefore, to maximise uptake and plasma concentrations of vitamin C, the chosen oral dose should ideally be administered in several smaller doses over the day.<xref rid="R47" ref-type="bibr">47</xref> Vitamin C has low toxicity and is not believed to cause serious adverse effects at high intakes. The most common complaints are diarrhoea, nausea, abdominal cramps and other gastrointestinal disturbances due to the osmotic effect of unabsorbed vitamin C in the gastrointestinal tract.<xref rid="R45" ref-type="bibr">45</xref>A tolerable upper limit of 2000&#8201;mg per day of vitamin C has been established,<xref rid="R48" ref-type="bibr">48</xref> and adverse events, including oxalate nephropathy or haemolysis in glucose-6-phosphate dehydrogenase-deficient patients, are reported for short course of vitamin C only with very high dosage (up to 60&#8201;g intravenous over 2&#8201;days) or solely for studies using lower dosages during to many months.<xref rid="R49" ref-type="bibr">49 50</xref></p><p>Considering dosages used in studies performed in acute postoperative and chronic pain context, adverse events reported with different dosages, and the absorption of vitamin C given orally, we will compare the effect of 1000&#8201;mg vitamin C taken orally two times a day (one in the morning and one in the evening) for a 14-day period after ED discharge for the treatment arm to a placebo for the control arm.</p></sec><sec id="s2-3-3"><title>Subject compliance monitoring</title><p>All participants will be asked to complete a 14-day electronic or paper diary. Each day, participants will be asked whether they took both their study-capsule and whether they started using a new vitamin or natural product. Reminders will be sent electronically to patients using the electronic diary, while phone calls will be used for patients completing the paper version. Results from our previous work<xref rid="R3" ref-type="bibr">3 37 51</xref> suggest that nearly all patients fully understood how to fill out the diary and questionnaire and found them easy to complete.</p></sec></sec><sec id="s2-4"><title>Study procedures</title><p>After verifying all eligibility criteria, the research assistant will document the following initial data in REDCap: unique patient identifier, demographic variables (sex, gender, age and ethnicity), phone numbers, email address, complaint and pain location at triage, pain duration before ED visit, ED length of stay, final diagnosis (injury type and severity), history of opioid use or substance use disorder, analgesics received during ED stay, pain intensity at triage and discharge, pain medication prescribed at discharge, usual medication, vitamins and natural products, other non-pharmacological approach (ice, heat, immobilisation, etc), and if it was a work or motor vehicle-related incident. A pharmacist will dispense either active or placebo capsules and patients will be informed not to start consuming any other vitamin or natural products. All participating patients will be granted online access to an already validated 14-day electronic diary and questionnaire. An identical paper version (also previously tested) of the 14-day diary and questionnaire will be provided to patients without internet access or less familiar with smartphones. Patients will be instructed in person on how to use the electronic or paper diary and to start with acetaminophen and NSAID (if prescribed) before consuming opioids. Patients will also have phone access to research assistants should they require assistance.</p><p>Electronic questionnaires are generally favoured over phone interviews because they may be less affected by social desirability bias.<xref rid="R52" ref-type="bibr">52</xref> This diary is used daily for real-time recording of quantity, date and names of all pain medications consumed, including vitamin C, related to the patient&#8217;s ED visit. At the end of each day, pain intensity will be assessed by one question: &#8216;What was your pain level throughout the day?&#8217; measured on an 11-point numerical rating scale (NRS) from 0 to 10 (0 is no pain and 10 is worst pain imaginable) and, in general, if their pain had been relieved during the day (yes or no). Participants will be asked at the end of each day if they took their two study capsules (see paper version of the diary example in <xref rid="SP1" ref-type="supplementary-material">online supplemental file 1</xref>).</p><p>At the end of 2&#8201;weeks, patients will have a scheduled visit (in person or virtual depending on the patient&#8217;s preference), where they will bring all their medications. A series of questions will be asked regarding their actual pain intensity level as measured on an 11-point NRS from 0 to 10 (0 is no pain and 10 is worst pain imaginable), the frequency of their pain during a typical week, if they filled their initial opioid prescription (including partitioning), if they received additional opioid prescriptions (this will be verified with their pharmacy), their reasons for stopping or not taking any opioids (not enough or no pain, overly severe side effects, fear of addiction, other), unscheduled clinician visits related to their initial pain condition, if their medications were adequate for their overall pain management, and if they had any other treatment for their pain (surgery, physiotherapy, acupuncture, etc). They will also report which of the following side effects were experienced during the 14-day period: nausea, vomiting, constipation, dizziness, drowsiness, sweating, weakness or other side effects. If a serious unexpected adverse reaction is fatal or life threatening, the research team will notify as soon as possible the Natural Health Products Directorate no later than 7&#8201;days after the research team became aware of it, and no later than 15 days if the unexpected serious adverse reaction is neither fatal nor life threatening. They will be asked whether they started any other product to relieve pain (cannabis, alcohol, vitamins, other natural or over-the-counter products, etc). As mitigation strategy, we will count the remaining morphine pills and study capsules, which will allow us to retrieve our main outcome for patients without (or incomplete) 14-day diary (see SPIRIT study design schedule in <xref rid="T1" ref-type="table">table 1</xref>).</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p>Study design schedule according to the standard protocol items: recommendations for interventional trials</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom" rowspan="3" colspan="1">Timepoint</td><td align="left" valign="bottom" rowspan="1" colspan="6">
<italic toggle="yes">Study period</italic>
</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Enrolment</td><td align="left" valign="bottom" rowspan="1" colspan="1">Allocation</td><td align="left" valign="bottom" rowspan="1" colspan="3">Post-allocation</td><td align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Safety follow-up</italic>
</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Week 0</italic>
</td><td align="left" valign="bottom" rowspan="1" colspan="1">Week 0</td><td align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Week 1</italic>
</td><td align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Week 2</italic>
</td><td align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Week 12</italic>
</td><td align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Week 52</italic>
</td></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Enrolment:</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Eligibility screen</td><td align="left" valign="top" rowspan="1" colspan="1"><named-content content-type="indent">&#8195;</named-content><named-content content-type="indent">&#8195;</named-content>X</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Informed consent</td><td align="left" valign="top" rowspan="1" colspan="1"><named-content content-type="indent">&#8195;</named-content><named-content content-type="indent">&#8195;</named-content>X</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Allocation</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"><named-content content-type="indent">&#8195;</named-content><named-content content-type="indent">&#8195;</named-content>X</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Interventions:</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Vitamin C</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="2">
<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bmjopen-2022-069230ilf01.jpg"/>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Placebo</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="2">
<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bmjopen-2022-069230ilf02.jpg"/>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Assessments:</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Baseline variables</td><td align="left" valign="top" rowspan="1" colspan="1"><named-content content-type="indent">&#8195;</named-content><named-content content-type="indent">&#8195;</named-content>X</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="char" char="hyphen" valign="top" rowspan="1" colspan="1">
<bold>14-day diary:</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;<italic toggle="yes">Daily pain medication</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="2">
<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bmjopen-2022-069230ilf03.jpg"/>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;<italic toggle="yes">Daily vitamin C intake</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="2">
<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bmjopen-2022-069230ilf04.jpg"/>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;<italic toggle="yes">Daily pain intensity NRS</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="2">
<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bmjopen-2022-069230ilf05.jpg"/>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;<italic toggle="yes">Daily pain relief</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="2">
<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bmjopen-2022-069230ilf06.jpg"/>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;<italic toggle="yes">14-day side effects</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"><named-content content-type="indent">&#8195;</named-content><named-content content-type="indent">&#8195;</named-content><named-content content-type="indent">&#8195;</named-content>X</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;<italic toggle="yes">Postdiary evaluation in person or virtual visit</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">X</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;<italic toggle="yes">Pain intensity NRS</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"><named-content content-type="indent">&#8195;</named-content><named-content content-type="indent">&#8195;</named-content>X</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;<italic toggle="yes">Pain frequency</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"><named-content content-type="indent">&#8195;</named-content><named-content content-type="indent">&#8195;</named-content>X</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;<italic toggle="yes">Pain disability index</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"><named-content content-type="indent">&#8195;</named-content><named-content content-type="indent">&#8195;</named-content>X</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;<italic toggle="yes">CRPS in person visit using Budapest criteria*</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"><named-content content-type="indent">&#8195;</named-content><named-content content-type="indent">&#8195;</named-content>X</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8195;Rapid Opioid Dependence Screen&#8224;</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"><named-content content-type="indent">&#8195;</named-content><named-content content-type="indent">&#8195;</named-content><named-content content-type="indent">&#8195;</named-content>X</td></tr></tbody></table><table-wrap-foot><fn id="T1_FN1"><p>*For those who still have pain caused by limb fracture.</p></fn><fn id="T1_FN2"><p>&#8224;For those who still consumed opioids 1 year after initial ED visit.</p></fn><fn id="T1_FN3"><p>CRPS, complex regional pain syndromes; ED, emergency department; NRS, numerical rating scale from 0 to 10 (0 is no pain and 10 is worst pain imaginable).</p></fn></table-wrap-foot></table-wrap><p>At 3&#8201;months, patients will be contacted by phone to determine whether they suffer from chronic pain. A series of questions will be asked: their actual pain intensity level as measured on an 11-point NRS from 0 to 10 (0 is no pain and 10 worst pain imaginable), if they still consumed opioids in the last 2&#8201;weeks, medication used for pain, pain frequency during a typical week and to answer the Pain Disability Index (PDI) questionnaire.<xref rid="R53" ref-type="bibr">53</xref> The PDI is made up of seven categories that are measured on a scale from 0 (no disability) to 10 (all of the individual&#8217;s normal activities have been totally disrupted or impossible because of pain). Family and household responsibilities, recreation, social activities, occupation, sexual activities, independence and life support activities make up the seven areas of the PDI. Subsequently, a total score is calculated by adding the responses to the seven items to give a PDI score, which can be between 0 and 70. The percentage obtained can correspond to five diagnose: 0%&#8211;20% (minimal disability), 21%&#8211;40% (moderate disability), 41%&#8211;60% (severe disability), 61%&#8211;80% (infirm) and 81&#8211;%100% (bedridden). Chronic pain will be defined as at least as moderate disability on the PDI. The 3-month follow-up period was chosen because pain is usually considered chronic when it persists or recurs for more than 3&#8201;months.<xref rid="R54" ref-type="bibr">54</xref> Patients will also be asked whether their medications were adequate for their overall pain management. For patients with limb fractures who are still in pain, an in-person visit will be scheduled to evaluate the presence of CRPS defined by the Budapest criteria, which includes a physical examination (see <xref rid="B1" ref-type="boxed-text">box 1</xref>).<xref rid="R55" ref-type="bibr">55</xref></p><boxed-text id="B1" position="float" orientation="portrait"><label>Box 1</label><caption><title>Budapest clinical diagnostic criteria for complex regional pain syndrome</title></caption><list list-type="order"><list-item><p>Continuing pain, which is disproportionate to any inciting event.</p></list-item><list-item><p>Must report at least one symptom in <italic toggle="yes">three of the four</italic> following categories.</p><list list-type="bullet"><list-item><p><italic toggle="yes">Sensory:</italic> reports of hyperesthesia and/or allodynia.</p></list-item><list-item><p><italic toggle="yes">Vasomotor:</italic> reports of temperature asymmetry and/or skin colour changes and/or skin colour asymmetry.</p></list-item><list-item><p><italic toggle="yes">Sudomotor/oedema:</italic> reports of oedema and/or sweating changes and/or sweating asymmetry.</p></list-item><list-item><p><italic toggle="yes">Motor/trophic:</italic> reports of decreased range of motion and/or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nail, skin).</p></list-item></list></list-item><list-item><p>Must display at least one sign at time of evaluation in <italic toggle="yes">two or more</italic> of the following categories:</p><list list-type="bullet"><list-item><p><italic toggle="yes">Sensory:</italic> evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch and/or deep somatic pressure and/or joint movement).</p></list-item><list-item><p><italic toggle="yes">Vasomotor:</italic> evidence of temperature asymmetry and/or skin colour changes and/or asymmetry.</p></list-item><list-item><p><italic toggle="yes">Sudomotor/oedema:</italic> evidence of oedema and/or sweating changes and/or sweating asymmetry.</p></list-item><list-item><p><italic toggle="yes">Motor/trophic:</italic> evidence of decreased range of motion and/or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nail, skin).</p></list-item></list></list-item><list-item><p>There is no other diagnosis that better explains the signs and symptoms</p></list-item></list></boxed-text><p>Patients who had filled their initial opioid prescription will be contacted by phone 1&#8201;year after their initial visit and asked whether they consumed opioids in the previous 2&#8201;weeks. For patients who still consumed opioids, they will be asked to answer questions on opioid dependence using the rapid opioid dependence screen (RODS)<xref rid="R56" ref-type="bibr">56</xref> as well as their reasons for consuming opioids. The RODS questionnaire is a newly validated<xref rid="R56" ref-type="bibr">56</xref> measure of opioid dependence. This tool, composed of eight &#8216;yes/no&#8217; questions, is designed to evaluate opioid dependence in clinical and research settings and is based on the Diagnostic and Statistical Manual of Mental Disorders V.IV. It takes 2&#8201;min to complete, and patients are considered as possibly opioid dependent if they answered positively to three or more of the eight items. This questionnaire has shown good internal consistency (&#945;=0.92), fair inter-item correlations (0.66 to 0.87) and strong sensitivity (0.97) and specificity (0.76) when compared with a neuropsychiatric interview. Patients who meet the criteria for possible opioid dependency will be referred to an opioid use disorder clinic near their location.</p></sec><sec id="s2-5"><title>Statistical analysis</title><sec id="s2-5-1"><title>Sample size determination</title><p>The effect of vitamin C on 24-hour postoperative opioid consumption was used to compute treatment effect size for our primary outcome (total morphine 5&#8201;mg pills consumed after a 2-week follow-up). Two studies using oral route of vitamin C were reported, one by Kanazi <italic toggle="yes">et al</italic><xref rid="R57" ref-type="bibr">57</xref> and one by Tunay <italic toggle="yes">et al</italic>.<xref rid="R58" ref-type="bibr">58</xref> To be more conservative, we used the study with the smallest treatment effect (Tunay) and calculated an effect size of d=0.32. Anticipating a similar treatment effect, 190 participants in each arm are necessary to achieve a power of 0.90 with an alpha of 0.05 (PASS, V.11.0). Given the 18% lost to follow-up rate observed during a previous study using the same diary,<xref rid="R37" ref-type="bibr">37</xref> a total of 464 patients will be recruited.</p><p>Previous studies made on the same population have shown an average recruitment rate of two participants per day at our study site.<xref rid="R37" ref-type="bibr">37</xref> Therefore, an 8-month period will be necessary to enrol the initial sample. Accounting for the 3-month follow-up period and another 12 months for safety follow-up, a total of approximately 24 months will be required for recruitment and follow-up.</p></sec><sec id="s2-5-2"><title>Analysis plan and statistical methods</title><p>We propose an intention to treat analysis with an additional per-protocol analysis. Mann-Whitney U test or t-test, depending on data distributions, will be used to compare the total morphine 5&#8201;mg pills consumed after a 2-week follow-up between both arms. Although participants will be stratified by type of painful condition and randomised into the two arms, we will compare their distributions for potential confounding variables by calculating group-specific means and proportions, as appropriate.<xref rid="R59" ref-type="bibr">59</xref> As a sensitivity analysis, we will use a multiple regression analysis to evaluate the effect of vitamin C on total 5&#8201;mg pills consumed controlling for coanalgesic use, sex/gender, age, and ethnicity.</p><p>To compare pain intensity trajectories between both groups, group-based trajectory modelling (GBTM) will be used. GBTM is a statistical tool that identifies groups of patients with similar behavioural evolution over time without assuming the existence of a specific trend or number of groups.<xref rid="R60" ref-type="bibr">60</xref> This new tool offers a more flexible approach of identifying linear or non-linear trajectories of pain evolution.<xref rid="R61" ref-type="bibr">61</xref> Complete description of the modelling was reported in a previous work.<xref rid="R51" ref-type="bibr">51</xref> A &#967;<sup>2</sup> test will be used to compare the proportion of patients within each trajectory between each arm.</p><p>Proportion of participants with pain relief, and side effect during the 14-day follow-up, opioid use, chronic pain and CRPS at 3&#8201;months will be tested using &#967;<sup>2</sup> tests. Multiple comparison adjustments using false discovery rate are planned to control for inflated alpha error rate. Results will be presented using effect size with their 95% CIs. No interim analysis is planned and consequently the study will not be terminated earlier.</p></sec><sec id="s2-5-3"><title>Missing outcome data</title><p>Missing data and dropouts will be assessed monthly by the data manager. Remedial measures, including staff retraining, will be used as needed to minimise missing data and patients lost to follow-up. For statistical analysis, potential missing data will be estimated using multiple imputation approach based on previous identified predictors if data are missing at random. It creates several different plausible imputed data sets and appropriately combining results obtained from each of them.<xref rid="R62" ref-type="bibr">62</xref></p></sec></sec><sec id="s2-6"><title>Patient and public involvement</title><p>A patient partner was involved in the study design and in the paper and electronic version of the pain medication diary that will be used in this study.</p></sec></sec><sec id="s3"><title>Ethics and dissemination</title><sec id="s3-1"><title>Ethics approval</title><p>This study has been granted ethics approval from the local Ethics Review Committee. Any protocol deviations will be submitted to the Ethics Review Committee for review.</p></sec><sec id="s3-2"><title>Data management</title><p>Confidential and informed consent will occur in a private room. Every precaution will be taken to ensure data confidentiality. Only research team members will have access to both the paper and electronic data. Subjects will be assigned a unique study ID that will be used on all case report forms and database reporting. The database will be REDCap, which is HIPAA compliant, encrypted and password protected. Electronic data files will be accessible only on password-protected computers. Any hard copies will be maintained in a locked cabinet in a locked office by a member of the research team. There will be strict adherence to data management protocols. All source documents and trial documentation will be kept in a secure location by the investigators for 15 years.</p><p>The study investigators will have full access to and ownership of all data. Deidentified data will be made available to other interested investigators for additional analyses, on reasonable request, following reports of primary outcomes and with appropriate data use agreement.</p><p>The trial steering committee, who will also act as the data safety committee and will be composed of six members: principal investigator, project manager, research coordinator, biostatistician, clinical pharmacist and one ED clinician. It will oversee all study progress aspects and ensure participants safety, monitor recruitment, data collection and quality. Monitoring will be done monthly while any serious adverse events will be reported immediately to the committee, which will notify the REB and the Natural Health Products Directorate.</p></sec><sec id="s3-3"><title>Dissemination plan</title><p>We plan to use the study data to write a manuscript for publication in a respected peer-reviewed journal in a timely fashion. Journal choice will be dependent on study findings but will likely be related to the fields of pain and emergency medicine. The principal author is a member of national/regional committees on pain management/opioid use, and part of a Canadian research network which will facilitate knowledge transfer. Results will likely be presented at national and international conferences.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="d64e238" position="float" orientation="portrait"><caption><title>Reviewer comments</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bmjopen-2022-069230.reviewer_comments.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material content-type="local-data" id="d64e239" position="float" orientation="portrait"><caption><title>Author's
manuscript</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bmjopen-2022-069230.draft_revisions.pdf" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack><p>We would like to thank Martin Marquis for English language editing.</p></ack><fn-group><fn fn-type="other"><p><bold>Contributors:</bold> RD and JP conceived the study and obtained research funding. RD, JP, J-MC, DW, VH, CA, ME, DR and AC contributed to the final protocol and data interpretation. JP was responsible for data management and statistical analysis. RD drafted the manuscript. JP, J-MC, DW, VH, CA, ME, DR and AC contributed substantially to its revision. RD, JP, J-MC, DW, VH, CA, ME, DR and AC approved the final manuscript as submitted and have agreed to be accountable for all aspects of the work.</p></fn><fn fn-type="other"><p><bold>Funding:</bold> This research was supported by the 'Fonds des Urgentistes de l&#8223;H&#244;pital du Sacr&#233;-C&#339;ur de Montr&#233;al'.</p></fn><fn fn-type="COI-statement"><p><bold>Competing interests:</bold> None declared.</p></fn><fn fn-type="other"><p><bold>Patient and public involvement:</bold> Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.</p></fn><fn fn-type="other"><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn><fn fn-type="other"><p><bold>Supplemental material:</bold> This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p></fn></fn-group><sec sec-type="ethics-statement"><title>Ethics statements</title><sec><title>Patient consent for publication</title><p content-type="ethics-consent-to-publish">Not applicable.</p></sec></sec><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gleber</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Vilke</surname><given-names>GM</given-names></string-name>, <string-name name-style="western"><surname>Castillo</surname><given-names>EM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Trends in emergency physician opioid Prescribing practices during the United States opioid crisis</article-title>. <source>Am J Emerg Med</source><year>2020</year>;<volume>38</volume>:<fpage>735</fpage>&#8211;<lpage>40</lpage>.:<elocation-id>S0735-6757(19)30388-2</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.ajem.2019.06.011</pub-id><pub-id pub-id-type="pmid">31227419</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ali</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Cutler</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Mutter</surname><given-names>R</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Opioid prescribing rates from the emergency department: down but not out</article-title>. <source>Drug and Alcohol Dependence</source><year>2019</year>;<volume>205</volume>:<elocation-id>107636</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2019.107636</pub-id><pub-id pub-id-type="pmid">31704377</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Daoust</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Paquet</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cournoyer</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Side effects from opioids used for acute pain after emergency Department discharge</article-title>. <source>Am J Emerg Med</source><year>2020</year>;<volume>38</volume>:<fpage>695</fpage>&#8211;<lpage>701</lpage>.:<elocation-id>S0735-6757(19)30378-X</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.ajem.2019.06.001</pub-id><pub-id pub-id-type="pmid">31182367</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Boom</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Niesters</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sarton</surname><given-names>E</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Non-analgesic effects of opioids: Opioid-induced respiratory depression</article-title>. <source>Curr Pharm Des</source><year>2012</year>;<volume>18</volume>:<fpage>5994</fpage>&#8211;<lpage>6004</lpage>. <pub-id pub-id-type="doi">10.2174/138161212803582469</pub-id><pub-id pub-id-type="pmid">22747535</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Barnett</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Olenski</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Jena</surname><given-names>AB</given-names></string-name></person-group>. <article-title>Opioid-Prescribing patterns of emergency physicians and risk of long-term use</article-title>. <source>N Engl J Med Overseas Ed</source><year>2017</year>;<volume>376</volume>:<fpage>663</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMsa1610524</pub-id><pub-id pub-id-type="pmcid">PMC5428548</pub-id><pub-id pub-id-type="pmid">28199807</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hoppe</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Heard</surname><given-names>K</given-names></string-name></person-group>. <article-title>Association of Emergency Department Opioid Initiation With Recurrent Opioid Use</article-title>. <source>Annals of Emergency Medicine</source><year>2015</year>;<volume>65</volume>:<fpage>493</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.annemergmed.2014.11.015</pub-id><pub-id pub-id-type="pmid">25534654</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Beaudoin</surname><given-names>FL</given-names></string-name>, <string-name name-style="western"><surname>Straube</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lopez</surname><given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Prescription opioid misuse among ED patients discharged with opioids</article-title>. <source>Am J Emerg Med</source><year>2014</year>;<volume>32</volume>:<fpage>580</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajem.2014.02.030</pub-id><pub-id pub-id-type="pmid">24726759</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hasegawa</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Espinola</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>DFM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Trends in U.S. emergency department visits for opioid overdose, 1993&#8211;2010</article-title>. <source>Pain Med</source><year>2014</year>;<volume>15</volume>:<fpage>1765</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1111/pme.12461</pub-id><pub-id pub-id-type="pmid">25139712</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dhalla</surname><given-names>IA</given-names></string-name>, <string-name name-style="western"><surname>Mamdani</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Sivilotti</surname><given-names>MLA</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone</article-title>. <source>CMAJ</source><year>2009</year>;<volume>181</volume>:<fpage>891</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1503/cmaj.090784</pub-id><pub-id pub-id-type="pmid">19969578</pub-id><pub-id pub-id-type="pmcid">PMC2789126</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kurteva</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Abrahamowicz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Gomes</surname><given-names>T</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Association of opioid consumption profiles after hospitalization with risk of adverse health care events</article-title>. <source>JAMA Netw Open</source><year>2021</year>;<volume>4</volume>:<fpage>e218782</fpage>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.8782</pub-id><pub-id pub-id-type="pmid">34003273</pub-id><pub-id pub-id-type="pmcid">PMC8132136</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Poon</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Greenwood-Ericksen</surname><given-names>MB</given-names></string-name></person-group>. <article-title>The opioid prescription epidemic and the role of emergency medicine</article-title>. <source>Ann Emerg Med</source><year>2014</year>;<volume>64</volume>:<fpage>490</fpage>&#8211;<lpage>5</lpage>.:<elocation-id>S0196-0644(14)00527-7</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.annemergmed.2014.06.016</pub-id><pub-id pub-id-type="pmid">25017821</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>del Portal</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Healy</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Satz</surname><given-names>WA</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Impact of an opioid Prescribing guideline in the acute care setting</article-title>. <source>J Emerg Med</source><year>2016</year>;<volume>50</volume>:<fpage>21</fpage>&#8211;<lpage>7</lpage>.:<elocation-id>S0736-4679(15)00621-6</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.jemermed.2015.06.014</pub-id><pub-id pub-id-type="pmid">26281819</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Doyon</surname><given-names>S</given-names></string-name></person-group>. <article-title>A performance improvement Prescribing guideline reduces opioid prescriptions for emergency Department dental pain patients</article-title>. <source>Ann Emerg Med</source><year>2014</year>;<volume>63</volume>:<fpage>371</fpage>.:<elocation-id>S0196-0644(13)01483-2</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.annemergmed.2013.09.033</pub-id><pub-id pub-id-type="pmid">24528948</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Delgado</surname><given-names>MK</given-names></string-name>, <string-name name-style="western"><surname>Shofer</surname><given-names>FS</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>MS</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Association between electronic medical record implementation of default opioid prescription quantities and Prescribing behavior in two emergency departments</article-title>. <source>J Gen Intern Med</source><year>2018</year>;<volume>33</volume>:<fpage>409</fpage>&#8211;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1007/s11606-017-4286-5</pub-id><pub-id pub-id-type="pmid">29340937</pub-id><pub-id pub-id-type="pmcid">PMC5880773</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Santistevan</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Sharp</surname><given-names>BR</given-names></string-name>, <string-name name-style="western"><surname>Hamedani</surname><given-names>AG</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>By default: the effect of Prepopulated prescription quantities on opioid prescribing in the emergency department</article-title>. <source>West J Emerg Med</source><year>2018</year>;<volume>19</volume>:<fpage>392</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.5811/westjem.2017.10.33798</pub-id><pub-id pub-id-type="pmid">29560071</pub-id><pub-id pub-id-type="pmcid">PMC5851516</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Daoust</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Paquet</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Marquis</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Evaluation of interventions to reduce opioid Prescribing for patients discharged from the emergency Department: A systematic review and meta-analysis</article-title>. <source>JAMA Netw Open</source><year>2022</year>;<volume>5</volume>:<elocation-id>e2143425</elocation-id>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.43425</pub-id><pub-id pub-id-type="pmid">35024834</pub-id><pub-id pub-id-type="pmcid">PMC8759006</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kunze</surname><given-names>KN</given-names></string-name>, <string-name name-style="western"><surname>Polce</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Lilly</surname><given-names>DT</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Adjunct analgesia reduces pain and opioid consumption after hip arthroscopy: a systematic review of randomized controlled trials</article-title>. <source>Am J Sports Med</source><year>2020</year>;<volume>48</volume>:<fpage>3638</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1177/0363546520905884</pub-id><pub-id pub-id-type="pmid">32119562</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>George</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Baker</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Leonard</surname><given-names>CE</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Risk of Nonunion with nonselective NSAIDs, COX-2 inhibitors, and opioids</article-title>. <source>J Bone Joint Surg Am</source><year>2020</year>;<volume>102</volume>:<fpage>1230</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.2106/JBJS.19.01415</pub-id><pub-id pub-id-type="pmid">32675672</pub-id><pub-id pub-id-type="pmcid">PMC7508275</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sondergaard</surname><given-names>KB</given-names></string-name>, <string-name name-style="western"><surname>Weeke</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Wissenberg</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Non-Steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: A nationwide case-time-control study</article-title>. <source>Eur Heart J Cardiovasc Pharmacother</source><year>2017</year>;<volume>3</volume>:<fpage>100</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/ehjcvp/pvw041</pub-id><pub-id pub-id-type="pmid">28025218</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Li</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Shen</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>X</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Vitamin C enhances the analgesic effect of Gabapentin on rats with neuropathic pain</article-title>. <source>Life Sci</source><year>2016</year>;<volume>157</volume>:<fpage>25</fpage>&#8211;<lpage>31</lpage>.:<elocation-id>S0024-3205(16)30333-2</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.lfs.2016.05.035</pub-id><pub-id pub-id-type="pmid">27245275</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Newman</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Connery</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Opioids</surname><given-names>BoydJ</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Known interactions and potential for Redox-Signaling crosstalk</article-title>. <source>Antioxidants</source><year>2022</year>;<volume>11</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antiox11071267</pub-id><pub-id pub-id-type="pmcid">PMC9312198</pub-id><pub-id pub-id-type="pmid">35883757</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Carr</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>McCall</surname><given-names>C</given-names></string-name></person-group>. <article-title>The role of vitamin C in the treatment of pain: new insights</article-title>. <source>J Transl Med</source><year>2017</year>;<volume>15</volume>. <pub-id pub-id-type="doi">10.1186/s12967-017-1179-7</pub-id><pub-id pub-id-type="pmcid">PMC5391567</pub-id><pub-id pub-id-type="pmid">28410599</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Oakes</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Bolia</surname><given-names>IK</given-names></string-name>, <string-name name-style="western"><surname>Weber</surname><given-names>AE</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Vitamin C in orthopedic practices: current concepts, novel ideas, and future perspectives</article-title>. <source>J Orthop Res</source><year>2021</year>;<volume>39</volume>:<fpage>698</fpage>&#8211;<lpage>706</lpage>. <pub-id pub-id-type="doi">10.1002/jor.24947</pub-id><pub-id pub-id-type="pmid">33300201</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ka&#378;mierczak-Bara&#324;ska</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Boguszewska</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Adamus-Grabicka</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Two faces of vitamin C-antioxidative and pro-oxidative agent</article-title>. <source>Nutrients</source><year>2020</year>;<volume>12</volume>:<elocation-id>1501</elocation-id>. <pub-id pub-id-type="doi">10.3390/nu12051501</pub-id><pub-id pub-id-type="pmid">32455696</pub-id><pub-id pub-id-type="pmcid">PMC7285147</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chaitanya</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Muthukrishnan</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Krishnaprasad</surname><given-names>CMS</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>An insight and update on the analgesic properties of vitamin C</article-title>. <source>J Pharm Bioall Sci</source><year>2018</year>;<volume>10</volume>:<fpage>119</fpage>&#8211;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.4103/JPBS.JPBS_12_18</pub-id><pub-id pub-id-type="pmcid">PMC6142887</pub-id><pub-id pub-id-type="pmid">30237682</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chen</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Roffey</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Dion</surname><given-names>C-A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Effect of perioperative vitamin C supplementation on postoperative pain and the incidence of chronic regional pain syndrome: A systematic review and meta-analysis</article-title>. <source>Clin J Pain</source><year>2016</year>;<volume>32</volume>:<fpage>179</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1097/AJP.0000000000000218</pub-id><pub-id pub-id-type="pmid">25654537</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hung</surname><given-names>K-C</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>Y-T</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>K-H</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The effect of perioperative vitamin C on postoperative analgesic consumption: A meta-analysis of randomized controlled trials</article-title>. <source>Nutrients</source><year>2020</year>;<volume>12</volume>:<elocation-id>3109</elocation-id>. <pub-id pub-id-type="doi">10.3390/nu12103109</pub-id><pub-id pub-id-type="pmid">33053814</pub-id><pub-id pub-id-type="pmcid">PMC7600013</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Moon</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lim</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Cho</surname><given-names>K</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The efficacy of vitamin C on postlaparoscopic shoulder pain: a double-blind randomized controlled trial</article-title>. <source>Anesth Pain Med</source><year>2019</year>;<volume>14</volume>:<fpage>202</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.17085/apm.2019.14.2.202</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pisalsitsakul</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Pinnoi</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Sutanthavibul</surname><given-names>N</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Taking 200&#8201;mg vitamin C three times per day improved extraction socket wound healing parameters: A randomized clinical trial</article-title>. <source>Int J Dent</source><year>2022</year>;<volume>2022</volume>:<elocation-id>6437200</elocation-id>. <pub-id pub-id-type="doi">10.1155/2022/6437200</pub-id><pub-id pub-id-type="pmid">35310461</pub-id><pub-id pub-id-type="pmcid">PMC8930268</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Na</surname><given-names>CH</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>A study of intravenous administration of vitamin C in the treatment of acute herpetic pain and postherpetic neuralgia</article-title>. <source>Ann Dermatol</source><year>2016</year>;<volume>28</volume>:<elocation-id>677</elocation-id>. <pub-id pub-id-type="doi">10.5021/ad.2016.28.6.677</pub-id><pub-id pub-id-type="pmid">27904265</pub-id><pub-id pub-id-type="pmcid">PMC5125947</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shibuya</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Humphers</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Agarwal</surname><given-names>MR</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Efficacy and safety of high-dose vitamin C on complex regional pain syndrome in extremity trauma and surgery--systematic review and meta-analysis</article-title>. <source>J Foot Ankle Surg</source><year>2013</year>;<volume>52</volume>:<fpage>62</fpage>&#8211;<lpage>6</lpage>.:<elocation-id>S1067-2516(12)00392-4</elocation-id>. <pub-id pub-id-type="doi">10.1053/j.jfas.2012.08.003</pub-id><pub-id pub-id-type="pmid">22985495</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>A&#239;m</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Klouche</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Frison</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Efficacy of vitamin C in preventing complex regional pain syndrome after wrist fracture: A systematic review and meta-analysis</article-title>. <source>Orthop Traumatol Surg Res</source><year>2017</year>;<volume>103</volume>:<fpage>465</fpage>&#8211;<lpage>70</lpage>.:<elocation-id>S1877-0568(17)30055-5</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.otsr.2016.12.021</pub-id><pub-id pub-id-type="pmid">28274883</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Seth</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Bulloch</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Seth</surname><given-names>N</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Effect of perioperative vitamin C on the incidence of complex regional pain syndrome: A systematic review and meta-analysis</article-title>. <source>J Foot Ankle Surg</source><year>2022</year>;<volume>61</volume>:<fpage>748</fpage>&#8211;<lpage>54</lpage>.:<elocation-id>S1067-2516(21)00460-9</elocation-id>. <pub-id pub-id-type="doi">10.1053/j.jfas.2021.11.008</pub-id><pub-id pub-id-type="pmid">34961681</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jacques</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>J&#233;r&#244;me</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Antoine</surname><given-names>C</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Prospective randomized study of the vitamin C effect on pain and complex pain regional syndrome after total knee Arthroplasty</article-title>. <source>Int Orthop</source><year>2021</year>;<volume>45</volume>:<fpage>1155</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1007/s00264-020-04936-9</pub-id><pub-id pub-id-type="pmid">33438072</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Keef</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Keef</surname><given-names>S</given-names></string-name></person-group>. <article-title>The efficacy of vitamin C in the prevention of complex regional pain syndrome after distal radius fractures: A synthesis</article-title>. <source>J Pain Palliat Care Pharmacother</source><year>2018</year>;<volume>32</volume>:<fpage>208</fpage>&#8211;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1080/15360288.2019.1598530</pub-id><pub-id pub-id-type="pmid">30998426</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bonica</surname><given-names>JJ</given-names></string-name></person-group>. <article-title>The need of a taxonomy</article-title>. <source>Pain</source><year>1979</year>;<volume>6</volume>:<fpage>247</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/0304-3959(79)90046-0</pub-id><pub-id pub-id-type="pmid">460931</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Daoust</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Paquet</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cournoyer</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Quantity of opioids consumed following an emergency department visit for acute pain: a Canadian prospective cohort study</article-title>. <source>BMJ Open</source><year>2018</year>;<volume>8</volume>:<elocation-id>e022649</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmjopen-2018-022649</pub-id><pub-id pub-id-type="pmcid">PMC6144484</pub-id><pub-id pub-id-type="pmid">30224393</pub-id></mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Moher</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Hopewell</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Schulz</surname><given-names>KF</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Consort 2010 statement: Updated guidelines for reporting parallel group randomised trials</article-title>. <source>BMJ</source><year>2010</year>;<volume>340</volume>:<elocation-id>c869</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmj.c869</pub-id><pub-id pub-id-type="pmid">20332511</pub-id><pub-id pub-id-type="pmcid">PMC2844943</pub-id></mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chan</surname><given-names>A-W</given-names></string-name>, <string-name name-style="western"><surname>Tetzlaff</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Altman</surname><given-names>DG</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>SPIRIT 2013 statement: Defining standard protocol items for clinical trials</article-title>. <source>Ann Intern Med</source><year>2013</year>;<volume>158</volume>:<fpage>200</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-158-3-201302050-00583</pub-id><pub-id pub-id-type="pmid">23295957</pub-id><pub-id pub-id-type="pmcid">PMC5114123</pub-id></mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ekrol</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Duckworth</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Ralston</surname><given-names>SH</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The influence of vitamin C on the outcome of distal radial fractures: a double-blind, randomized controlled trial</article-title>. <source>J Bone Joint Surg Am</source><year>2014</year>;<volume>96</volume>:<fpage>1451</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.2106/JBJS.M.00268</pub-id><pub-id pub-id-type="pmid">25187584</pub-id></mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rosenstock</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Joab</surname><given-names>TMJ</given-names></string-name>, <string-name name-style="western"><surname>DeVita</surname><given-names>MV</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Oxalate nephropathy: a review</article-title>. <source>Clin Kidney J</source><year>2022</year>;<volume>15</volume>:<fpage>194</fpage>&#8211;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1093/ckj/sfab145</pub-id><pub-id pub-id-type="pmid">35145635</pub-id><pub-id pub-id-type="pmcid">PMC8825217</pub-id></mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lane</surname><given-names>DJR</given-names></string-name>, <string-name name-style="western"><surname>Richardson</surname><given-names>DR</given-names></string-name></person-group>. <article-title>The active role of vitamin C in mammalian iron metabolism: much more than just enhanced iron absorption!</article-title><source>Free Radical Biology and Medicine</source><year>2014</year>;<volume>75</volume>:<fpage>69</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2014.07.007</pub-id><pub-id pub-id-type="pmid">25048971</pub-id></mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="webpage"><article-title>Uptodate vitamin C (Ascorbic acid): Drug information</article-title>. <year>2022</year>. <comment>Available</comment>: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information?search=vitamin%20c&amp;source=panel_search_result&amp;selectedTitle=1~148&amp;usage_type=panel&amp;kp_tab=drug_general&amp;display_rank=1">https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information?search=vitamin%20c&amp;source=panel_search_result&amp;selectedTitle=1~148&amp;usage_type=panel&amp;kp_tab=drug_general&amp;display_rank=1</uri> [Accessed <comment>2 Mar 2022</comment>].</mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Shin</surname><given-names>W</given-names></string-name></person-group>. <article-title>How to do random allocation (randomization)</article-title>. <source>Clin Orthop Surg</source><year>2014</year>;<volume>6</volume>:<elocation-id>103</elocation-id>. <pub-id pub-id-type="doi">10.4055/cios.2014.6.1.103</pub-id><pub-id pub-id-type="pmid">24605197</pub-id><pub-id pub-id-type="pmcid">PMC3942596</pub-id></mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>Institute of Medicine</collab></person-group>. <source>Food and nutrition board. dietary reference intakes for vitamin C, vitamin E, selenium, and Carotenoidsexternal link disclaimer</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academy Press</publisher-name>, <year>2000</year>.</mixed-citation></ref><ref id="R46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Levine</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Conry-Cantilena</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance</article-title>. <source>Proc Natl Acad Sci U S A</source><year>1996</year>;<volume>93</volume>:<fpage>3704</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.8.3704</pub-id><pub-id pub-id-type="pmid">8623000</pub-id><pub-id pub-id-type="pmcid">PMC39676</pub-id></mixed-citation></ref><ref id="R47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Padayatty</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Vitamin C pharmacokinetics: Implications for oral and intravenous use</article-title>. <source>Ann Intern Med</source><year>2004</year>;<volume>140</volume>:<fpage>533</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-140-7-200404060-00010</pub-id><pub-id pub-id-type="pmid">15068981</pub-id></mixed-citation></ref><ref id="R48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hathcock</surname><given-names>JN</given-names></string-name>, <string-name name-style="western"><surname>Azzi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Blumberg</surname><given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Vitamins E and C are safe across a broad range of intakes</article-title>. <source>Am J Clin Nutr</source><year>2005</year>;<volume>81</volume>:<fpage>736</fpage>&#8211;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/81.4.736</pub-id><pub-id pub-id-type="pmid">15817846</pub-id></mixed-citation></ref><ref id="R49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lin</surname><given-names>WV</given-names></string-name>, <string-name name-style="western"><surname>Turin</surname><given-names>CG</given-names></string-name>, <string-name name-style="western"><surname>McCormick</surname><given-names>DW</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Ascorbic acid-induced oxalate nephropathy: A case report and discussion of pathologic mechanisms</article-title>. <source>CEN Case Rep</source><year>2019</year>;<volume>8</volume>:<fpage>67</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1007/s13730-018-0366-6</pub-id><pub-id pub-id-type="pmid">30276648</pub-id><pub-id pub-id-type="pmcid">PMC6361085</pub-id></mixed-citation></ref><ref id="R50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Youngster</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Arcavi</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Schechmaster</surname><given-names>R</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Medications and Glucose-6-phosphate dehydrogenase deficiency: An evidence-based review</article-title>. <source>Drug Saf</source><year>2010</year>;<volume>33</volume>:<fpage>713</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.2165/11536520-000000000-00000</pub-id><pub-id pub-id-type="pmid">20701405</pub-id></mixed-citation></ref><ref id="R51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Daoust</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Paquet</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cournoyer</surname><given-names>A</given-names></string-name></person-group>. <article-title>Acute pain resolution after an emergency department visit: a 14-day trajectory analysis</article-title>. <source>Annals of Emergency Medicine</source>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.annemergmed.2019.01.019</pub-id><pub-id pub-id-type="pmid">30797575</pub-id></mixed-citation></ref><ref id="R52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Brener</surname><given-names>ND</given-names></string-name>, <string-name name-style="western"><surname>Billy</surname><given-names>JOG</given-names></string-name>, <string-name name-style="western"><surname>Grady</surname><given-names>WR</given-names></string-name></person-group>. <article-title>Assessment of factors affecting the validity of self-reported health-risk behavior among adolescents: Evidence from the scientific literature</article-title>. <source>J Adolesc Health</source><year>2003</year>;<volume>33</volume>:<fpage>436</fpage>&#8211;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/s1054-139x(03)00052-1</pub-id><pub-id pub-id-type="pmid">14642706</pub-id></mixed-citation></ref><ref id="R53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pollard</surname><given-names>CA</given-names></string-name></person-group>. <article-title>Preliminary validity study of the pain disability index</article-title>. <source>Percept Mot Skills</source><year>1984</year>;<volume>59</volume>:<elocation-id>974</elocation-id>. <pub-id pub-id-type="doi">10.2466/pms.1984.59.3.974</pub-id><pub-id pub-id-type="pmid">6240632</pub-id></mixed-citation></ref><ref id="R54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Treede</surname><given-names>R-D</given-names></string-name>, <string-name name-style="western"><surname>Rief</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Barke</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>A classification of chronic pain for ICD-11</article-title>. <source>Pain</source><year>2015</year>;<volume>156</volume>:<fpage>1003</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000000160</pub-id><pub-id pub-id-type="pmid">25844555</pub-id><pub-id pub-id-type="pmcid">PMC4450869</pub-id></mixed-citation></ref><ref id="R55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Harden</surname><given-names>NR</given-names></string-name>, <string-name name-style="western"><surname>Bruehl</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Perez</surname><given-names>RSGM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Validation of proposed diagnostic criteria (the &#8220;Budapest Criteria&#8221;) for Complex Regional Pain Syndrome</article-title>. <source>Pain</source><year>2010</year>;<volume>150</volume>:<fpage>268</fpage>&#8211;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2010.04.030</pub-id><pub-id pub-id-type="pmid">20493633</pub-id><pub-id pub-id-type="pmcid">PMC2914601</pub-id></mixed-citation></ref><ref id="R56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wickersham</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Azar</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Cannon</surname><given-names>CM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Validation of a brief measure of opioid dependence: the rapid opioid dependence screen (rods)</article-title>. <source>J Correct Health Care</source><year>2015</year>;<volume>21</volume>:<fpage>12</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1177/1078345814557513</pub-id><pub-id pub-id-type="pmid">25559628</pub-id><pub-id pub-id-type="pmcid">PMC4435561</pub-id></mixed-citation></ref><ref id="R57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kanazi</surname><given-names>GE</given-names></string-name>, <string-name name-style="western"><surname>El-Khatib</surname><given-names>MF</given-names></string-name>, <string-name name-style="western"><surname>Yazbeck- Karam</surname><given-names>VG</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Effect of vitamin C on morphine use after laparoscopic cholecystectomy: a randomized controlled trial</article-title>. <source>Can J Anaesth</source><year>2012</year>;<volume>59</volume>:<fpage>538</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1007/s12630-012-9692-x</pub-id><pub-id pub-id-type="pmid">22402954</pub-id></mixed-citation></ref><ref id="R58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lafl&#305; Tunay</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>T&#252;rke&#252;n Ilg&#305;nel</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>&#220;nl&#252;gen&#231;</surname><given-names>H</given-names></string-name></person-group>. <article-title>Comparison of the effects of preoperative melatonin or vitamin C administration on postoperative analgesia</article-title>. <source>Bosn J Basic Med Sci</source><year>2020</year>;<volume>20</volume>:<fpage>117</fpage>&#8211;<lpage>24</lpage>.<pub-id pub-id-type="pmid">31465720</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.17305/bjbms.2019.4379</pub-id><pub-id pub-id-type="pmcid">PMC7029201</pub-id></mixed-citation></ref><ref id="R59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dijkman</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Kooistra</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Bhandari</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>How to work with a subgroup analysis</article-title>. <source>Can J Surg</source><year>2009</year>;<volume>52</volume>:<fpage>515</fpage>&#8211;<lpage>22</lpage>.<pub-id pub-id-type="pmid">20011190</pub-id><pub-id pub-id-type="pmcid">PMC2792383</pub-id></mixed-citation></ref><ref id="R60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nagin</surname><given-names>DS</given-names></string-name>, <string-name name-style="western"><surname>Odgers</surname><given-names>CL</given-names></string-name></person-group>. <article-title>Group-Based trajectory modeling in clinical research</article-title>. <source>Annu Rev Clin Psychol</source><year>2010</year>;<volume>6</volume>:<fpage>109</fpage>&#8211;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.clinpsy.121208.131413</pub-id><pub-id pub-id-type="pmid">20192788</pub-id></mixed-citation></ref><ref id="R61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Daoust</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Emond</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bergeron</surname><given-names>E</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Risk factors of significant pain syndrome 90 days after minor thoracic injury: trajectory analysis</article-title>. <source>Acad Emerg Med</source><year>2013</year>;<volume>20</volume>:<fpage>1139</fpage>&#8211;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1111/acem.12248</pub-id><pub-id pub-id-type="pmid">24238316</pub-id></mixed-citation></ref><ref id="R62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sterne</surname><given-names>JAC</given-names></string-name>, <string-name name-style="western"><surname>White</surname><given-names>IR</given-names></string-name>, <string-name name-style="western"><surname>Carlin</surname><given-names>JB</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Multiple imputation for missing data in Epidemiological and clinical research: Potential and pitfalls</article-title>. <source>BMJ</source><year>2009</year>;<volume>338</volume>:<elocation-id>b2393</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmj.b2393</pub-id><pub-id pub-id-type="pmid">19564179</pub-id><pub-id pub-id-type="pmcid">PMC2714692</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>